胰島素筆針的全球市場
市場調查報告書
商品編碼
1427004

胰島素筆針的全球市場

Global Insulin Pen Market

出版日期: | 出版商: BCC Research | 英文 78 Pages | 訂單完成後即時交付

價格

本報告調查了全球胰島素筆針市場,並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析、競爭形勢以及主要企業總結。

目錄

第1章 簡介

第2章 摘要/亮點

  • 市場展望
  • 市場摘要
  • 報告亮點

第3章 市場概述/定義

  • 概述
  • 糖尿病
  • 1型糖尿病
  • 2型糖尿病
  • 胰島素的作用
  • 糖尿病治療
  • 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機會
  • 市場挑戰

第4章 市場細分:依地區

  • 市場概覽/討論
  • 市場規模/預測
  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第5章 市場區隔:依發病時間

  • 市場概覽/討論
  • 長效胰島素
  • 速效胰島素
  • 中效胰島素
  • 短效胰島素
  • 市場規模/預測
  • 長效胰島素筆針
  • 中間胰島素筆針
  • 短效胰島素筆針
  • 速效胰島素筆針

第6章 市場細分:依最終用戶分類

  • 市場概況
  • 醫院
  • 藥局
  • 市場規模/預測
  • 全球胰島素筆針依最終用戶分類的市場
  • 依最終用戶分類的北美市場
  • 依最終用戶分類的歐洲市場
  • 依最終用戶分類的亞太市場
  • 其他地區最終用戶市場

第7章 ESG發展

  • 環境
  • 社群
  • 管治
  • 案例研究
  • Novo Nordisk A/S
  • BCC的結語

第8章 競爭形勢

  • 概述及行業場景
  • 企業市場占有率
  • 近期主要進展

第9章 公司簡介

  • ASTRAZENECA
  • BIOCON
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • ELI LILLY AND CO.
  • JOHNSON & JOHNSON SERVICES INC.
  • MERCK & CO. INC.
  • NOVARTIS AG
  • NOVO NORDISK A/S
  • SANOFI
  • VIATRIS INC.

第10章 附錄:首字母縮寫詞

Product Code: MDS102A

This report examines the global insulin pen market. It includes a detailed analysis and prediction of commercially significant products such as reusable and disposable insulin pens. This report investigates global insulin pen market patterns and features between 2022–2028, offering valuable insights and forecasts.

Report Scope:

This report thoroughly examines the worldwide market size of global insulin pen delivery technology, enhancing its appeal to stakeholders and readers alike. Current and historical market revenues are estimated based on the type, duration, end user and region.

Report Includes:

  • An overview of the global market for insulin pen
  • Analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Evaluation of the current market size and revenue growth prospects specific to insulin pen, accompanied by a comprehensive market share analysis categorized by type, onset time, end user, and geographical region
  • A look at the innovations, technological advancements, and the launch of novel products from market players
  • Detailed analysis of the regulatory framework and policies and product pipeline of the industry, and discussion on ESG challenges and ESG practices in the insulin pen market
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
  • Comprehensive company profiles of the leading players of the industry

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Information Sources
  • Secondary Research
  • Geographic Breakdown
  • Segmentation Breakdown

Chapter 2 Summary and Highlights

  • Market Outlook
  • Market Summary
  • Report Highlights

Chapter 3 Market Overview and Definitions

  • Overview
  • Diabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Role of Insulin
  • Diabetes Treatment
  • Market Dynamics
  • Market Drivers
  • Market Restrains
  • Market Opportunities
  • Market Challenges

Chapter 4 Market Breakdown by Region

  • Market Overview and Discussion
  • Market Size and Forecast
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 5 Market Breakdown by Onset Time

  • Market Overview and Discussion
  • Long-Acting Insulin
  • Rapid-Acting Insulin
  • Intermediate-Acting Insulin
  • Short-Acting Insulin
  • Market Size and Forecast
  • Long-Acting Insulin Pens
  • Intermediate-Acting Insulin Pens
  • Short-Acting Insulin Pens
  • Rapid-Acting Insulin Pens

Chapter 6 Market Breakdown by End User

  • Market Overview
  • Hospitals
  • Pharmacies
  • Market Size and Forecast
  • Global Insulin Pen End-Users Market
  • North American End-User Market
  • European End-User Market
  • Asia-Pacific End-User Market
  • Rest of the World End-User Market

Chapter 7 ESG Development

  • Introduction
  • Environmental
  • Social
  • Governance
  • Case Study
  • Novo Nordisk A/S
  • Concluding Remarks from BCC

Chapter 8 Competitive Landscape

  • Overview and Industry Scenario
  • Company Shares
  • Recent Key Developments

Chapter 9 Company Profiles

  • ASTRAZENECA
  • BIOCON
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • ELI LILLY AND CO.
  • JOHNSON & JOHNSON SERVICES INC.
  • MERCK & CO. INC.
  • NOVARTIS AG
  • NOVO NORDISK A/S
  • SANOFI
  • VIATRIS INC.

Chapter 10 Appendix: Acronyms

  • List of Acronyms

List of Tables

  • Summary Table : Global Market for Insulin Pens, by Type, Through 2028
  • Table 1 : Global Insulin Pens Market Drivers
  • Table 2 : Global Insulin Pens Market Restraints
  • Table 3 : Global Insulin Pens Market Challenges
  • Table 4 : Global Market for Insulin Pens, by Region, Through 2028
  • Table 5 : North American Market for Insulin Pens, by Type, Through 2028
  • Table 6 : European Market for Insulin Pens, by Type, Through 2028
  • Table 7 : Asia-Pacific Market for Insulin Pens, by Type, Through 2028
  • Table 8 : Rest of the World Market for Insulin Pens, by Type, Through 2028
  • Table 9 : Insulin Type and Features
  • Table 10 : Leading Insulin Products and Their Types
  • Table 11 : Global Market for Insulin Pens, by Onset Time, Through 2028
  • Table 12 : Global Market for Long-Acting Insulin Pens, by Region, Through 2028
  • Table 13 : Global Market for Intermediate-Acting Insulin Pens, by Region, Through 2028
  • Table 14 : Global Market for Short- Acting Insulin Pens, by Region, Through 2028
  • Table 15 : Global Market for Rapid-Acting Insulin Pens, by Region, Through 2028
  • Table 16 : Global Market for Insulin Pens for Hospitals, by Region, Through 2028
  • Table 17 : Global Market for Insulin Pens for Pharmacies, by Region, Through 2028
  • Table 18 : North American Market for Insulin Pens, by End User, Through 2028
  • Table 19 : European Market for Insulin Pens, by End User, Through 2028
  • Table 20 : Asia-Pacific Market for Insulin Pens, by End User, Through 2028
  • Table 21 : Rest of the World Market for Insulin Pens, by End User, Through 2028
  • Table 22 : Top Pharma Companies' ESG Risk Ratings
  • Table 23 : Novo Nordisk A/S: Key Environmental Performance Indicators, 2020-2022
  • Table 24 : Novo Nordisk A/S: Key Social Performance Indicators, 2020-2022
  • Table 25 : Novo Nordisk A/S: Key Governance Performance Indicators, 2020-2022
  • Table 26 : Global Market Share of Insulin Pens, by Company, 2022
  • Table 27 : Global Market Shares of Insulin Pens, by Product, 2022
  • Table 28 : Global Insulin Market, Product Sales Revenue, 2020-2022
  • Table 29 : Global Diabetes Treatment Market, Selected Recent Key Developments, September 2019-August 2022
  • Table 30 : AstraZeneca: Company Snapshot
  • Table 31 : AstraZeneca: Diabetology Product Information
  • Table 32 : AstraZeneca: Revenue, 2020-2022
  • Table 33 : AstraZeneca: Recent Key Developments, 2021-2023
  • Table 34 : Biocon: Company Snapshot
  • Table 35 : Biocon: Diabetology Product Information
  • Table 36 : Biocon: Revenue, 2020-2022
  • Table 37 : Biocon: Key Developments, 2021-2023
  • Table 38 : Boehringer Ingelheim International GmbH: Company Snapshot
  • Table 39 : Boehringer Ingelheim International GmbH: Diabetology Product Information
  • Table 40 : Boehringer Ingelheim International GmbH: Annual Revenue, 2020-2022
  • Table 41 : Boehringer Ingelheim International GmbH: Key Developments, 2019-2021
  • Table 42 : Eli Lilly and Co.: Company Snapshot
  • Table 43 : Eli Lilly and Co: Diabetology Product Information
  • Table 44 : Eli Lilly and Co: Annual Revenue, 2020-2022
  • Table 45 : Eli Lilly and Co: Recent Key Developments, 2020-2022
  • Table 46 : Johnson & Johnson Services Inc.: Company Snapshot
  • Table 47 : Johnson & Johnson Services Inc.: Diabetology Product Information
  • Table 48 : Johnson & Johnson Services Inc.: Annual Revenue, 2020-2022
  • Table 49 : Merck & Co. Inc.: Company Snapshot
  • Table 50 : Merck & Co. Inc.: Diabetology Product Information
  • Table 51 : Merck & Co. Inc.: Financials, 2020-2022
  • Table 52 : Merck & Co. Inc.: Key Developments, 2021
  • Table 53 : Novartis AG: Company Snapshot
  • Table 54 : Novartis AG: Diabetology Product Information
  • Table 55 : Novartis AG: Financials, 2020-2022
  • Table 56 : Novartis AG: Key Developments, 2023
  • Table 57 : Novo Nordisk A/S: Company Snapshot
  • Table 58 : Novo Nordisk A/S: Diabetology Product Information
  • Table 59 : Novo Nordisk A/S: Revenue, 2020-2022
  • Table 60 : Novo Nordisk A/S: Recent Developments, 2019-2022
  • Table 61 : Sanofi: Company Snapshot
  • Table 62 : Sanofi: Business Segment
  • Table 63 : Sanofi: Diabetology Product Information
  • Table 64 : Sanofi: Annual Revenue, 2020-2022
  • Table 65 : Sanofi: Key Developments, 2021-2023
  • Table 66 : Viatris Inc.: Company Snapshot
  • Table 67 : Viatris Inc.: Annual Revenue, 2020-2022
  • Table 68 : Viatris Inc.: Diabetology Product Information
  • Table 69 : Major Acronyms Used in This Report

List of Figures

  • Summary Figure A : Global Market for Insulin Pens, by Type, 2020-2028
  • Summary Figure B : Global Market Shares of Insulin Pens, by Type, 2022
  • Figure 1 : Market Dynamics for the Global Insulin Pens Market
  • Figure 2 : Global Market Shares of Insulin Pens, by Region, 2022
  • Figure 3 : North American Market Shares of Insulin Pens, by Type, 2022
  • Figure 4 : European Market Shares of Insulin Pens, by Type, 2022
  • Figure 5 : Asia-Pacific Market Shares of Insulin Pens, by Type, 2022
  • Figure 6 : Rest of the World Market Shares of Insulin Pens, by Type, 2022
  • Figure 7 : Global Market Shares of Insulin Pens, by Onset Time, 2022
  • Figure 8 : Global Market Shares of Long-Acting Insulin Pens, by Region, 2022
  • Figure 9 : Global Market Shares of Intermediate-Acting Insulin Pens, by Region, 2022
  • Figure 10 : Global Market Shares of Short-Acting Insulin Pens, by Region, 2022
  • Figure 11 : Global Market Shares of Rapid-Acting Insulin Pens, by Region, 2022
  • Figure 12 : North American Market Shares for Insulin Pens, by End User, 2022
  • Figure 13 : European Market Shares for Insulin Pens, by End User, 2022
  • Figure 14 : Asia-Pacific Market Shares for Insulin Pens, by End User, 2022
  • Figure 15 : Rest of the World Market Shares for Insulin Pens, by End User, 2022
  • Figure 16 : Global Market Shares of Insulin Pens, by Company, 2022
  • Figure 17 : Global Market Shares of Insulin Pens, by Product, 2022
  • Figure 18 : Global Insulin Market, by Product, Sales Revenue, 2022
  • Figure 19 : AstraZeneca: Revenue Share, by Country, 2022
  • Figure 20 : Merck & Co. Inc.: Annual Revenue, by Segment, 2020-2022
  • Figure 21 : Novartis AG: Innovative Medicine, Market Share, by Region, 2022
  • Figure 22 : Novartis AG: Market Share, by Region, 2022
  • Figure 23 : Sanofi: Annual Revenue, by Region, 2022
  • Figure 24 : Sanofi: Revenue, by Segment, 2022
  • Figure 25 : Viatris Inc.: Sales Share, by Region, 2022